Chemed (CHE) Stock Price
Chemed Price
Revenue has compounded at 5.3% per year over the past 19 years to 2.43 B USD. Earnings per share have grown at 15.2% per year over the last 19 years. Chemed's net margin stands at 12.4%, down from 15.4% several years earlier. Chemed currently offers a dividend yield of about 0.37%. The payout ratio is around 9% of earnings. The dividend has grown at 9.9% per year over the past 19 years.
Chemed stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Chemed over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Chemed stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Chemed's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Chemed Price |
|---|
Chemed Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|
| 2.14 | 2.14 | 2.26 | 2.43 | 2.58 | 2.73 | 2.85 | 2.98 |
| 2.89 | -0.19 | 6.04 | 7.38 | 5.92 | 6.06 | 4.21 | 4.74 |
| 35.95 | 35.83 | 35.25 | 35.13 | 33.17 | 31.27 | 30.01 | 28.65 |
| 769 | 765 | 798 | 854 | 854 | 854 | 854 | 854 |
| 268 | 249 | 272 | 301 | 339 | 389 | 420 | 456 |
| -15.99 | -7.09 | 9.24 | 10.66 | 12.62 | 14.75 | 7.97 | 8.57 |
| 1.4 | 1.48 | 1.56 | 1.8 | 2.2 | 0.6 | 2.47 | - |
| 6.06 | 5.71 | 5.41 | 15.38 | 22.22 | -72.73 | 311.67 | – |
| 15.9 | 15.1 | 15.2 | 15.19 | 15.19 | 15.19 | 15.19 | 15.19 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Chemed generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Chemed retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Chemed's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Chemed has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Chemed's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Chemed stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed business model & stock analysis
Chemed SWOT Analysis
Strengths
Chemed Corp possesses several key strengths that contribute to its success:
- Strong brand reputation
- Diverse portfolio of services
- Experienced and skilled workforce
- High customer satisfaction
Weaknesses
Despite its strengths, Chemed Corp also faces certain weaknesses:
- Dependence on a few major customers
- Limited geographical reach
- Reliance on regulatory approvals
- Higher prices compared to competitors
Opportunities
Chemed Corp can explore several opportunities to further grow its business:
- Expansion into new markets
- Acquisition of complementary businesses
- Increased demand for healthcare services
- Technological advancements in the industry
Threats
Chemed Corp should also be aware of potential threats that may impact its operations:
- Intense competition in the healthcare sector
- Changes in government regulations
- Economic downturns affecting consumer spending
- Labor shortages and rising labor costs
Chemed Eulerpool Fair Value
Chemed historical P/E ratio, EBIT multiple, and P/S ratio
Chemed annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Chemed shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed Dividend History
37 years of dividend payments · 17 consecutive increases
Chemed dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 4/23/2026 | 5.36USD | 656.32 MUSD | 2026 Q1 |
| 2/25/2026 | 7.14USD | 665.68 MUSD | 2025 Q4 |
| 4/24/2024 | 5.5USD | 594.46 MUSD | 2024 Q1 |
| 2/21/2024 | 6.31USD | 592.51 MUSD | 2023 Q4 |
| 7/25/2023 | 5.02USD | 556.76 MUSD | 2023 Q2 |
| 4/24/2023 | 4.71USD | 548.66 MUSD | 2023 Q1 |
| 2/22/2023 | 5.37USD | 554.8 MUSD | 2022 Q4 |
| 10/31/2022 | 4.69USD | 534.96 MUSD | 2022 Q3 |
| 7/27/2022 | 4.82USD | 546.14 MUSD | 2022 Q2 |
| 4/26/2022 | 4.52USD | 546.64 MUSD | 2022 Q1 |
EESG©
Eulerpool ESG Scorecard© for the Chemed stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Chemed shareholder structure
| % | Name |
|---|---|
10.52956% | |
7.89041% | |
3.88408% | |
3.19309% | |
3.14114% | |
2.343% |
Chemed Executives and Management Board
Mr. Kevin Mcnamara
(71)President, Chief Executive Officer, Director · since 1986
Mr. Nicholas Westfall
(46)Executive Vice President
Mr. Michael Witzeman
(54)Chief Financial Officer, Vice President, Controller
Mr. Spencer Lee
(69)Executive Vice President · since 1999
Mr. Brian Judkins
(44)Vice President, Chief Legal Officer, Secretary
Chemed Supply Chain
Frequently asked questions about Chemed
The business model of Chemed Corp focuses on providing end-of-life care services through its subsidiaries, VITAS Healthcare and Roto-Rooter. Chemed Corp operates in two segments: VITAS, which offers hospice services to patients with life-limiting illnesses, and Roto-Rooter, a leading provider of plumbing and drain cleaning services. VITAS prioritizes compassionate care, aiming to enhance quality of life for patients and support their families. Roto-Rooter, on the other hand, provides essential plumbing solutions, specializing in emergency repairs, maintenance, and installation services. Chemed Corp's business model emphasizes delivering high-quality and specialized services in the healthcare and plumbing sectors, positioning itself as a reliable and trusted provider.
Chemed stock
Chemed Peer Group
Chemed Ticker
Chemed FIGI
All fundamentals and in-depth analysis of Chemed
Our stock analysis for Chemed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chemed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.